[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-IFRX":3,"homepage-market-summary":29,"stock-news-IFRX":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"IFRX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"InflaRx N.V. Common Stock","Nasdaq",null,"Common Stock","InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a\u002FC5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.","65",false,{"close":15,"open":16,"high":17,"low":15,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},1.72,1.74,1.8,1.71,0.01,0.58,422087.116945,2581,1.7492,2.949,0.79799998,1545619.64588606,42.9,2237,{"status":30,"indices":31,"watchlist":75,"sectors":97,"benchmarks":153},"success",[32,40,47,54,61,68],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":38,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":13,"sparkline":74,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":38,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":38,"sparkline":89,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":38,"sparkline":96,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[98,103,108,113,118,123,128,133,138,143,148],{"name":99,"etf":100,"change":101,"price":102,"is_up":38},"Technology","XLK",1.01,199.81,{"name":104,"etf":105,"change":106,"price":107,"is_up":38},"Financials","XLF",0.06,53.49,{"name":109,"etf":110,"change":111,"price":112,"is_up":13},"Healthcare","XLV",-0.01,166.18,{"name":114,"etf":115,"change":116,"price":117,"is_up":38},"Consumer Cycl","XLY",1.13,110.04,{"name":119,"etf":120,"change":121,"price":122,"is_up":38},"Consumer Staples","XLP",0.25,80.53,{"name":124,"etf":125,"change":126,"price":127,"is_up":38},"Energy","XLE",0.4,62.95,{"name":129,"etf":130,"change":131,"price":132,"is_up":38},"Industrials","XLI",0.78,169.95,{"name":134,"etf":135,"change":136,"price":137,"is_up":38},"Materials","XLB",0.66,48.86,{"name":139,"etf":140,"change":141,"price":142,"is_up":38},"Real Estate","XLRE",0.32,40.81,{"name":144,"etf":145,"change":146,"price":147,"is_up":38},"Utilities","XLU",0.38,39.83,{"name":149,"etf":150,"change":151,"price":152,"is_up":38},"Comm Services","XLC",0.35,110.32,[154,159,163,167],{"ticker":155,"name":156,"price":157,"change":158,"is_up":38},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":160,"name":161,"price":162,"change":88,"is_up":38},"QQQ","Invesco QQQ Trust",749.58,{"ticker":164,"name":165,"price":166,"change":52,"is_up":38},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":168,"name":169,"price":170,"change":66,"is_up":38},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":172,"articles":173},7,[174,180,186,192,198,204,210],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"InflaRx N.V. (IFRX) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFA3MnR6LXFvYWtneDczRlZiNHROMEZoYTh6VnZYQ3kzaHZfZmpMTnhNNFRZSDIzN2ZTZ04ybEs0a0FtSUhFTDljRDg0LXRhYkozVFE?oc=5","Sat, 03 Oct 2026 17:53:27 GMT","InflaRx N.V. (IFRX) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"An experimental drug showed promise in kidney disease models. InflaRx is set to present the findings at Kidney Week. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQZDY1YjVLaHdfa0szT1Zzb3hxRlpPN2pjalRtSzJPMXVKcHJOZGZvaWlFcGZ6ZEdJOUpjQkd2aDVkM1FDZktQTDd6a3FWcUNBekl0X0hlSHlxTzRzaC1QM2JoQ0xLOEt1cTBfa1VXbnA4TThvck1HTmE2S1Y2ZGJZTkhyV0tFajVIdTl5dFFRY2w4TVY0b3BRUlBmelVFYlFxUkk3RHQxazl0UklMT0NRWEJ4bGM1NkFhQWp0TUZn?oc=5","Fri, 02 Oct 2026 11:30:00 GMT","An experimental drug showed promise in kidney disease models. InflaRx is set to present the findings at Kidney Week. stocktitan.net","stocktitan.net",{"title":187,"link":188,"pubDate":189,"description":190,"source":191},"InflaRx N.V. (IFRX) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFAwWS1iWDFzems0TzZHaEhNem5JalNkR1Q0VUt6WVZzaWRBanZfNnltU0gxTkZOMjNUcjFPb1dDR0N5X0pPYjEtRjVJT0NGeGFsaWc?oc=5","Fri, 02 Oct 2026 17:08:59 GMT","InflaRx N.V. (IFRX) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"InflaRx N.V. Selected for Late-Breaking Kidney Week 2026 Poster on Izicopan Kidney Disease Models - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxNTkV5RTA4STB4ckx6aE1DSnRBYnlHOC1abm1qOTZpQnF3UmE0eHpIdW1ycUZUMy1xeDdSRUE2d1liNHIteFZ3SHcwT1RWUml0TFpWdFgxZHI5QkhGaFR4NHdUT092eDhidVJmbkpnRXNxNkdqeGNuODZkeVdZdFhLUjlGdHlkWHpkOG9BajZ1VEhmdFhBT2p6Z2ZoeUJadkVsWHJZa1VKLWczbmN5MUZwWTZJYTNBYzRGa3ZnT0Y3SkVHUEFFU1F5VkdB?oc=5","Fri, 02 Oct 2026 11:40:00 GMT","InflaRx N.V. Selected for Late-Breaking Kidney Week 2026 Poster on Izicopan Kidney Disease Models Quiver Quantitative","Quiver Quantitative",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"InflaRx appoints Gabriela Alperovich as head of clinical development By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxOLV9fSERQalIxd0t5cktuV3RkOW1odkkzQWFmdEVlNXhhYkY4ektwUXVMeG5sRDNybTJIQ0hzOHhiVWVCOXZrS2VrLXNvMlFXaXYtczlkZS1uUFRnMmFDaWYyTDlyZ051aWE3ZjJFQjhIcmlFUHZUTFRqMjBwcmRuaGpEQTBWdGZMV1Z6dXVjY0tzU3JDalY1TTVBX2twbHprLXdjZU0teTZOaEhTc21mUl9zUGFEZEVlX1JtOVFnVWxHUmNtNDAtQw?oc=5","Thu, 01 Oct 2026 12:54:46 GMT","InflaRx appoints Gabriela Alperovich as head of clinical development By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"IFOREX Financial Trading Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxQSE5nbF9VVUNLeVdkMzY2UjZiRWd3U3FSZmZhUzlTaXVva0dIZzRaTFBpSi1zYnRBbFYtOGtqWjBEOTRaN0pWdU5nQnhHOEFxUDVRMnNPclpVYjRhcU1aSURUOHBQSXd1ckk0LUhfNm90S1JWbENXc29VWnpRcUdOY2dQNFo5WUstYjUwSnpGX045MjFQeU94V3lGcU9zWW5yWWJHQjdYSFdqRlctemFfSHBxV0I3VHdKOS1pWmt3YnNfN0hvX0hBZldwMWpKMG8wcElKYWg4dUxBYlNJcTd1R0Y0VGJPUQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","IFOREX Financial Trading Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 marketscreener.com","marketscreener.com",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"iFOREX balances IPO milestone with profit pressure in first-half 2026 - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQZ1BKaXFJVFBFbi1aeW1ueTJqQUE3NDhQRUxmTndHdW9aSTlrTUtPTkRQWFVuQ0xfbTd5MjBRYW9GZ2M2MHM4bEg2d3d6QjA4Q1pad0VjcEpqcFR6MWNodUg2Tm5KbEpOZl9iQVZwNWl0Nl9EMXBUUlZuaU0tVVdhcWJXTEYtR2hLbkpHTE9PdGpYWVFneGI3WExoVXl5blYyMGJqZFo5bTNZcDRSclB6WnhkMjlkcXU2OVowSWV3?oc=5","Thu, 24 Sep 2026 06:54:23 GMT","iFOREX balances IPO milestone with profit pressure in first-half 2026 TipRanks","TipRanks"]